Understanding how a specific protein affects liver disease
Regulation and Function of Thioredoxin Interacting Protein (Txnip) in Nonalcoholic Steatohepatitis (NASH)
This study is looking at a protein called Txnip to see how it affects liver health in people with nonalcoholic steatohepatitis (NASH), and it aims to create a new treatment that could help improve liver function for those dealing with this tough condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11085102 on NIH RePORTER |
What this research studies
This research investigates the role of Thioredoxin Interacting Protein (Txnip) in nonalcoholic steatohepatitis (NASH), a severe form of liver disease with limited treatment options. The study aims to develop a new therapeutic approach by creating a Txnip inhibitor that targets its function specifically in the liver. Researchers will explore how Txnip contributes to liver cell death, which is a key factor in the progression of NASH. By focusing on the liver-specific effects of Txnip, the research seeks to provide insights that could lead to effective treatments for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with nonalcoholic steatohepatitis (NASH) who have not responded to existing treatments.
Not a fit: Patients with other forms of liver disease unrelated to NASH may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a novel therapy for patients with nonalcoholic steatohepatitis, potentially improving liver health and patient outcomes.
How similar studies have performed: While the role of Txnip in liver disease is being explored, this specific approach using a Txnip inhibitor is relatively novel and has not been extensively tested in clinical settings.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Yang, Ling — Temple Univ of the Commonwealth
- Study coordinator: Yang, Ling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.